» Articles » PMID: 28976641

Synthetic Biology and the Gut Microbiome

Overview
Journal Biotechnol J
Specialty Biotechnology
Date 2017 Oct 5
PMID 28976641
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiome plays a crucial role in maintaining human health. Functions performed by gastrointestinal microbes range from regulating metabolism to modulating immune and nervous system development. Scientists have attempted to exploit this importance through the development of engineered probiotics that are capable of producing and delivering small molecule therapeutics within the gut. However, existing synthetic probiotics are simplistic and fail to replicate the complexity and adaptability of native homeostatic mechanisms. In this review, the ways in which the tools and approaches of synthetic biology have been applied to improve the efficacy of therapeutic probiotics, and the ways in which they might be applied in the future is discussed. Simple devices, such as a bistable switches and integrase memory arrays, have been successfully implemented in the mammalian gut, and models for targeted delivery in this environment have also been developed. In the future, it will be necessary to introduce concepts such as logic-gating and biocontainment mechanisms into synthetic probiotics, as well as to expand the collection of relevant biosensors. Ideally, this will bring us closer to a reality in which engineered therapeutic microbes will be able to accurately diagnose and effectively respond to a variety of disease states.

Citing Articles

Open problems in synthetic multicellularity.

Sole R, Conde-Pueyo N, Pla-Mauri J, Garcia-Ojalvo J, Montserrat N, Levin M NPJ Syst Biol Appl. 2024; 10(1):151.

PMID: 39741147 PMC: 11688451. DOI: 10.1038/s41540-024-00477-8.


Biomimetic Materials to Fabricate Artificial Cells.

Peng H, Zhao M, Liu X, Tong T, Zhang W, Gong C Chem Rev. 2024; 124(23):13178-13215.

PMID: 39591535 PMC: 11671219. DOI: 10.1021/acs.chemrev.4c00241.


Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development.

Guo J, Yang L Biosci Microbiota Food Health. 2024; 43(4):293-299.

PMID: 39364128 PMC: 11444866. DOI: 10.12938/bmfh.2023-100.


Research trends of next generation probiotics.

Hasnain M, Kang D, Moon G Food Sci Biotechnol. 2024; 33(9):2111-2121.

PMID: 39130671 PMC: 11315851. DOI: 10.1007/s10068-024-01626-9.


Probiotics an emerging therapeutic approach towards gut-brain-axis oriented chronic health issues induced by microplastics: A comprehensive review.

Pan I, Umapathy S Heliyon. 2024; 10(11):e32004.

PMID: 38882279 PMC: 11176854. DOI: 10.1016/j.heliyon.2024.e32004.


References
1.
Shis D, Hussain F, Meinhardt S, Swint-Kruse L, Bennett M . Modular, multi-input transcriptional logic gating with orthogonal LacI/GalR family chimeras. ACS Synth Biol. 2014; 3(9):645-51. PMC: 4210161. DOI: 10.1021/sb500262f. View

2.
Garrett W, Lord G, Punit S, Lugo-Villarino G, Mazmanian S, Ito S . Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007; 131(1):33-45. PMC: 2169385. DOI: 10.1016/j.cell.2007.08.017. View

3.
Dinan T, Cryan J . Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. 2016; 595(2):489-503. PMC: 5233671. DOI: 10.1113/JP273106. View

4.
Yamamoto M, Matsumoto S . Gut microbiota and colorectal cancer. Genes Environ. 2016; 38:11. PMC: 4917993. DOI: 10.1186/s41021-016-0038-8. View

5.
Chan C, Lee J, Cameron D, Bashor C, Collins J . 'Deadman' and 'Passcode' microbial kill switches for bacterial containment. Nat Chem Biol. 2015; 12(2):82-6. PMC: 4718764. DOI: 10.1038/nchembio.1979. View